A round-up of EU competition law developments, including (amongst other things) (1) the Commission publishing a report on enforcement of EU antitrust and merger control rules in the pharmaceutical sector between 2018–2022, and (2) the Commission issues practical guidance for Member States on how to assess the existence of aid for risk finance measures.